Horizon Investments’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$34.8K Buy
946
+780
+470% +$37K ﹤0.01% 1148
2025
Q4
$8.45K Sell
166
-485
-75% -$24.8K ﹤0.01% 1174
2025
Q3
$36.1K Sell
651
-5,723
-90% -$335K ﹤0.01% 1011
2025
Q2
$440K Buy
6,374
+908
+17% +$61.8K 0.01% 827
2025
Q1
$380K Buy
5,466
+2,952
+117% +$244K 0.01% 419
2024
Q4
$216K Buy
2,514
+1,695
+207% +$183K 0.01% 526
2024
Q3
$97.5K Buy
819
+32
+4% +$4.27K ﹤0.01% 622
2024
Q2
$112K Buy
787
+40
+5% +$5.3K ﹤0.01% 620
2024
Q1
$95.9K Sell
747
-67
-8% -$7.98K ﹤0.01% 614
2023
Q4
$84.2K Sell
814
-286
-26% -$28.3K ﹤0.01% 603
2023
Q3
$100K Sell
1,100
-142
-11% -$12.5K ﹤0.01% 608
2023
Q2
$100K Buy
1,242
+70
+6% +$5.72K ﹤0.01% 606
2023
Q1
$93.3K Buy
+1,172
New +$83.1K ﹤0.01% 606
2019
Q4
Sell
-129,054
Closed -$3.34M 521
2019
Q3
$3.34M Buy
+129,054
New +$3.26M 0.14% 72
2017
Q4
Sell
-56,998
Closed -$1.16M 208
2017
Q3
$1.16M Buy
56,998
+13,470
+31% +$304K 0.07% 79
2017
Q2
$884K Sell
43,528
-934
-2% -$18.8K 0.05% 85
2017
Q1
$762K Buy
44,462
+23,980
+117% +$418K 0.05% 87
2016
Q4
$367K Buy
+20,482
New +$371K 0.03% 139

Other funds holding NVO

Horizon Investments's NVO Position: Q1 2026 in Review

Horizon Investments increased its Novo Nordisk (NVO) stake by 470% in Q1 2026, buying an estimated $37K and bringing the position to 946 shares worth $34.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1148.

Horizon Investments first reported a position in NVO in Q4 2016 and has held it in 18 quarters since. The position peaked at $3.34M in Q3 2019. 1,276 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Horizon Investments held 946 shares of Novo Nordisk worth $34.8K as of Q1 2026.
  • Horizon Investments bought 780 Novo Nordisk shares in Q1 2026, an estimated $37K.
  • Novo Nordisk made up ﹤0.01% of Horizon Investments's portfolio in Q1 2026, its #1148 holding.
  • Horizon Investments first reported a position in Novo Nordisk in Q4 2016 and has held it in 18 quarters since.
  • Horizon Investments's Novo Nordisk position peaked at $3.34M in Q3 2019.
  • 1,276 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Horizon Investments's 13F filing for Q1 2026, filed 15 May 2026.